Skip to Main

Jason Jager joined Boston Consulting Group in 2002. He currently leads the firm’s medtech and life science work for the US West Coast. Jason’s experience includes commercial, go-to-market, pricing, growth strategies, operational effectiveness, and M&A for a range of clients. He has worked for the firm in the Los Angeles, New York, Chicago, and Seoul offices. In addition, he has case experience in the fields of biopharma and life science, as well as extensive corporate development experience including integrations, carve-outs, and due diligence.

Prior to joining BCG, Jason worked in a variety of operational and manufacturing leadership roles for the Johnson Controls Inc. Automotive Systems Group both in North America and in Europe. While at the University of Michigan, Jason was a fellow with the Tauber Manufacturing Institute and the Department of Electrical Engineering.

AREAS OF EXPERTISE

EDUCATION

  • MBA/MEng, high distinction, Ross School of Business, University of Michigan
  • BS mechanical engineering, Massachusetts Institute of Technology

Publications and Videos

" "

Two Ways Genomic Sequencing Could Reshape Advanced Diagnostics

Costs for genomic sequencing have dropped steeply, making new types of genetic tests more accessible and changing the business model for the labs that run them.
Exterior shots of modern yellow-and-black apartment buildings

Next-Generation Pricing Is Transforming Medtech

Medtech companies have begun a long-overdue shift to disciplined, value-based pricing—the kind of pricing that can improve performance and fuel innovation.